Qing Kay Li

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ralph H. Hruban · 3 shared papers, 2015–2026 · strength 0.42
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
   • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
   • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
2. Daniel W. Chan · 2 shared papers, 2022–2026 · strength 0.39
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
   • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
3. Hui Zhang · 2 shared papers, 2022–2026 · strength 0.39
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
   • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
4. Oliver F. Bathe · 2 shared papers, 2022–2024 · strength 0.30
   • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
   • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
5. Bing Zhang · 2 shared papers, 2022–2024 · strength 0.30
   • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
   • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
6. Christine Worthington · 1 shared paper, 2026 · strength 0.27
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
7. Jongmin Jacob Woo · 1 shared paper, 2026 · strength 0.27
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
8. Randall E. Brand · 1 shared paper, 2026 · strength 0.27
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
9. Aatur Dilip Singhi · 1 shared paper, 2026 · strength 0.27
   • Paper High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. DOI 10.1021/acs.analchem.5c01928↗
10. Yuefan Wang · 1 shared paper, 2024 · strength 0.18
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
11. Sara R. Savage · 1 shared paper, 2024 · strength 0.18
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
12. Daniel Cui Zhou · 1 shared paper, 2022 · strength 0.12
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
13. Craig B Thompson · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
14. Peter James O'Dwyer · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
15. David C. Linehan · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
16. Carolyn Hruban · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
17. Mark Sausen · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
18. Victor E. Velculescu · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
19. Jeffrey A. Drebin · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
20. Peter J. Allen · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
21. Julia Sidenius Johansen · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
22. James R. Eshleman · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
23. Anirban Maitra · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
24. Luis Alberto Diaz · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
25. Daniel D. Von Hoff · 1 shared paper, 2015 · strength 0.04
    • Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.